Dabrafenib and/or Trametinib Rollover Study
Novartis
Novartis
NYU Langone Health
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Institut Paoli-Calmettes
University of Oklahoma
University of California, Davis
Jemincare
Kyowa Kirin Co., Ltd.
Hospices Civils de Lyon
Merck Sharp & Dohme LLC
SRH Wald-Klinikum Gera GmbH
Maastricht University Medical Center
Charite University, Berlin, Germany
LEO Pharma
LEO Pharma
Almirall, S.A.
Almirall, S.A.
Hull University Teaching Hospitals NHS Trust
Zealand University Hospital
Erasmus Medical Center
Psoriasis Treatment Center of Central New Jersey
RECORDATI GROUP
Royal Cornwall Hospitals Trust
University of California, Irvine
Medical University of Graz
Erasmus Medical Center
Clinigen, Inc.
Medical University of Graz
Wake Forest University Health Sciences
Assistance Publique Hopitaux De Marseille
Oslo University Hospital
Pierre Fabre Medicament
University Hospital, Bordeaux
University Medical Center Groningen
Peter MacCallum Cancer Centre, Australia
University Hospitals Cleveland Medical Center
Goldman, Butterwick, Fitzpatrick and Groff
University of California, San Francisco
Viatris Inc.
Viatris Inc.
Polish Lymphoma Research Group
Medical University of Graz
University of Michigan Rogel Cancer Center
VA Office of Research and Development
Novartis
Galderma R&D
University of Dundee
Galderma R&D
Clinigen, Inc.